Key highlights: Sales of Rs 1.67bn was up 8% yoy (+6% vs estimated). Healthy ATBS sales (+19%value&+29%volumegrowth)andincrementalsalesfromnewproductsstartingQ1 supportedrevenuegrowth.Withtheimprovingproductmixtowardsbettermarginproducts like ATBS and new launched ones, the EBITDA margins saw +390bps surprise at 35.6% (estimated31.7%),resultingin19%beatinEBITDAatRs596mn(estimatedRs500mn).The...